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Abstract
Argumentation theory (AT) has been gaining momentum
in the health care arena thanks to its intuitive and modu-
lar way of aggregating clinical evidence and taking ratio-
nal decisions. The basic principles of argumentation the-
ory are described and demonstrated in the breast cancer
recurrence problem. It is shown how to represent available
clinical evidence in arguments, how to define defeat rela-
tions among them and how to create a formal argumenta-
tion framework. Argumentation semantics are then applied
over the built framework to compute arguments justification
status. It is demonstrated how this process can enhance the
clinician decision-making process. A encouraging predic-
tive capacity is compared against the accuracy rate of well-
established machine learning techniques confirming the po-
tential of argumentation theory in health care.
1. Introduction
The amount of clinical evidence produced in health care
has been rapidly increasing thanks to the advent of Elec-
tronic Health Records and other technologies for assisting
clinicians, in their activities. Although this shift is good
for the advance of science and knowledge, it introduces dif-
ficulties for health practitioners in terms of degree of ef-
ficiency and accuracy in assimilating and acquiring clini-
cal evidence. In current health care settings, knowledge
and new evidence are often heterogeneous and complex,
inconsistent and incomplete. Intuitively, there is a tan-
gible need to aggregate pieces of evidence in a way that
reduces uncertainty and complexity, minimizing inconsis-
tency and incompleteness. Decision-making processes call
for a methodology capable of aggregating clinical knowl-
edge intuitively, accurately and able to cope with inconsis-
tency and conflicts among pieces of evidence.
To demonstrate Argumentation Theory (AT ) in practice,
we use a public available dataset concerned with breast can-
cer prognosis and/or recurrence [1]. Recurrence is a phe-
nomenon that defines the return of a cancer after treatments
and a temporal interval during which its detection is not pos-
sible. Predicting recurrence is important for assisting the
identification of patients with critical prognosis and mini-
mizing unnecessary therapies. A possible reasoning process
an clinician can perform to predict recurrence in a woman
who had a breast cancer surgery, is described in the follow-
ing. Firstly, the clinician may consider the tumor size at
the time of the surgery: a low size is a reason to believe
recurrence is not likely. However, if the patient is in a post-
menopausal state, the risk of recurrence is higher. Simi-
larly, from the clinician’s previous experience, if the degree
of malignancy of the cancer is low, there is a reason to be-
lieve recurrence is not likely but, if the number of involved
nodes in the cancer area is high, the risk of recurrence is
high. Arguments in such a discussion are knowledge-based
arguments: they are built according to the knowledge, ex-
perience and expertise of the clinician. The natural question
following such a discussion is: What is the final outcome of
the reasoning process? Let us assume the outcome is re-
currence: the cancer is likely to appear again. The problem
now is that the clinician will have to justify the decision.
The previous argument-based analysis is a form of defeasi-
ble reasoning, a kind of analysis and interpretation that is
based on reasons that are defeasible: a conclusion can be
retracted in the light of new evidence.
Defeasible reasoning has been gaining momentum
thanks to its ability to reason about unstructured clinical
situations, in uncertain domains where available informa-
tion is partial and sometimes contradictory. It can be mod-
eled via AT , a paradigm that studies how arguments can be
expressed, sustained and discarded, as well as the validity
of the conclusion reached. It deals with formal and com-
putable models, inspired by human-like reasoning. Its goal
is to apply formal semantics [2] among arguments to com-
pute their justification status.
This paper investigates the role of argumentation theory
in health care, reviewing existing work in section 2 and
introducing the building blocks of the theory in section 3.
Section 4 describes how the theory can be used in a illustra-
tive domain: the breast cancer recurrence prediction. A crit-
ical discussion of experimental results follows in Section 5,
highlighting the advantages and potential of argumentation
theory for enhancing and qualitatively explaining complex
decision-making processes. Section 6 summaries our con-
tribution and delineates future work.
2 Related work
Argumentation theory has evolved from its original pri-
mary context as a sub-discipline in philosophical logic, to
emerge, in the last decade, as an important area of logic-
based Artificial Intelligence (AI). The theory gained impor-
tance with the introduction of formal and computable mod-
els, inspired by human-like reasoning. These models ex-
tended the classical reasoning models based on deductive
logic that appeared increasingly inadequate for problems
requiring non-monotonic reasoning [3], commonly used by
humans, as well as explanatory reasoning, not available in
standard non-monotonic logics such as default logic. Non-
monotonic reasoning [4] differs from standard deductive
reasoning because in the former a conclusion can be re-
tracted in the light of new pieces of evidence, whereas in the
latter the set of conclusions always grows. Argumentation
lends itself to explanatory reasoning because argumentative
reasoning is composed of modular and intuitive steps, thus
avoiding the monolithic approach of many traditional log-
ics for non-monotonic reasoning. The reasoning required
in many decision-making processes, in health care, are both
non-monotonic and explanatory. Argumentation theory is
also suitable when the available information may be uncer-
tain and incomplete, as in health care, where there may be
relevant but partially conflicting information.
In health care, the first application area of argumen-
tation-based methodologies is decision-making. The Ex-
pected Utility Theory was firstly considered, a classical
quantitative formal approach to decision-making aimed at
arriving at rational decisions [9]. The theory advises to
compute the expected utility of different possible choices
and choose the one with the highest value. Despite its
power, the difficulty with the Expected Utility Theory is that
it requires lots of data to estimate the probabilities. Further-
more, the probabilistic and utility-based inferences are un-
natural to clinicians and difficult to understand for patients.
In the early 1990s, J. Fox and his group at Cancer Research
UK proposed an approach to decision-making under uncer-
tainty [9] in which logical methods are used to develop ar-
guments for and against competing clinical hypotheses such
as diagnoses, or actions such as therapies. Despite its sim-
plicity, the approach has proved to be surprisingly effective
for constructing practical decision support systems, and it
has high acceptability to clinicians.
Recently, models of argumentation have become increas-
ingly concerned not only with the formulation of individ-
ual arguments for beliefs or actions but also how arguments
may interact, particularly how certain kinds of argument can
attack and defeat other arguments [10, 13]. These models
have been inspired by the important contribution of Dung
[8] who proposed a very abstract methodology to deal with
a set of arguments that attack each other along with seman-
tics to compute extensions of arguments that can be seen
as justifiable. Over the years, Dung’s grounded and sta-
ble semantics have been applied in several studies and fur-
ther semantics have been proposed [2]. An example of such
a study is the work of Williams and Williamson aimed at
combining probability with logic for breast cancer progno-
sis [13]. The authors proposed to represent background
knowledge about breast cancer with logical formal argu-
ments, the qualitative explanation of the prognosis, while
they propose a Bayesian network to capture the probabilistic
relationships among the variable and to perform the progno-
sis. Argumentation theory has been used to aggregate clin-
ical evidence as well. The work of Hunter and Williams
[10] was focused on aggregating clinical knowledge in an
intuitive way and on reducing the inconsistency, complex-
ity, volume and incompleteness of the available evidence.
3 Formal Argumentation Theory
The underlying idea behind argumentation theory is that,
given a set of arguments, where some of them defeat (at-
tack) others, a decision is to be taken to determine which
arguments can ultimately be accepted. Merely looking at
an argument’s defeaters to determine the acceptability sta-
tus of an argument is not enough: it is also important to
determine whether the defeaters are defeated themselves.
Suppose a clinician is examining a 40 year old adult patient
already in post-menopausal status, who had a breast can-
cer operation, with a small tumor removed. He may reason
with 3 arguments, in respect to predicting recurrence: A:
‘patient’s medium age is a reason to believe no recurrence’ B: ‘pa-
tient’s post-menopausal status is a reason to believe recurrence’ C:
‘the size of removed tumor is low, no recurrence is believed’
A B C
Figure 1. Arguments and reinstatement (AF1)
We say that an argument B defeats argument A if, and
only if (iff), B is a reason against A. In our example, argu-
ment B defeats argument A, in fact, B supports recurrence
and A supports no recurrence. If the internal structure of ar-
guments, as well as the reasons why they defeat each other,
are not detailed, the structure is called abstract argumenta-
tion framework [8]. An argumentation framework is a
set of (abstract) arguments and binary defeat (attack) rela-
tions among these arguments. It specifies a directed graph
in which arguments are presented as nodes and the defeat
relations with arrows. Formally, an argumentation frame-
work is a pair AF = (Ar, def) where Ar is a set of argu-
ments and def ⊆ Ar×Ar. We say that A defeats B iff (A,
B) ∈ def . Now the question is which arguments should
ultimately be accepted. In fig. 1 A is defeated by B, and
apparently A should not be accepted since it has a coun-
terargument. However, B is itself defeated by C that is not
defeated by anything, thus C should be accepted. But if C is
accepted, then B is ultimately rejected and does not form a
reason against A anymore. Therefore A should be accepted
as well. In this situation we say that C reinstates A. Due
to this issue of reinstatement, a formal criterion that deter-
mines which arguments can be accepted, is needed. This
criterion is referred to as semantic, and given an argumen-
tation framework it specifies zero or more sets of acceptable
arguments, called extensions. Different argument based se-
mantics have been proposed [2], but here we focus on com-
plete, grounded and preferred semantics [8]. The issue of
argument semantics can be clarified using the labeling ap-
proach proposed by Wu and Caminada [15] (we refer the
reader to their works for formal definitions). Each argu-
ment is either in, out, undec according to the following
conditions: I) an argument is labelled in iff all its defeaters
are labelled out, and II) an argument is labelled out iff it
has at least one defeater that is labelled in. Informally, an
argument can have the label in if one has accepted the argu-
ment, out if rejected and undec if one abstains from taking
a position on either accepting or rejecting it. In Figure 1,
for argument C it holds that all its defeaters are labelled out
(trivial as C does not have any defeater), therefore C must
be labelled in. B now has a defeater labelled in therefore it
must be labelled out. For A, it holds that all its defeaters are
labelled out, so it must be labelled in. Thus the result is that
A, C are in and B is out.
• A set of argument is called conflict-free iff it does not
contain any argument A and B such that A defeats B.
• A set of arguments is said to defend an argument C iff
each defeater of C is defeated by an argument in Args.
• A function F yields the arguments defended by a given
set of arguments. It specifies the set of argument that
are acceptable, in the line of Dung [8].
• Given an argumentation framework, and Args a
conflict-free set of Arguments, Args is said to be a
complete extension iff Args = F (Args).
In the argumentation framework AF1 (Fig. 1) there is
just one complete extension, {A,C}, conflict-free that de-
fends exactly itself. Note {A,B,C} is also a fixpoint of F,
but is not a complete extension since it is not conflict-free.
Complete semantics have a important property: more than
one complete extension may exist. However, in some situ-
ation it is advantageous to apply a semantic that is guaran-
teed to yield exactly one extension: this is called Grounded
semantic. The idea is to select the complete extension in
which the set of in-labelled arguments is minimal.
The grounded extension coincides with the complete ex-
tension in which in is minimised, out is minimised and un-
dec is maximised. In Figure 1 the grounded extension is
{A,C}. Grounded semantics have the advantage that there
always exists exactly one grounded extension (it can be the
empty set), however this approach is a skeptical approach.
Preferred semantic deals with this limitation. The idea is
that preferred semantics, instead of maximizing undec ar-
guments, it maximises in arguments (and also out). It are
based on the concept of admissibility.
• A set of arguments is admissible iff it is conflict-free
and defends at least itself.
• Given an argumentation framework (Ar, def), and
Args ⊆ Ar, Args is said to be a preferred extension
iff Args is a maximal admissible set.
In Figure 1 there exist only one preferred extension
which is A,C. For any argumentation framework, there ex-
ist at least one preferred extension. A preferred extension
coincides with those labellings in which in is maximal and
out is maximal. It is important to note that every preferred
extension is a complete extension and every grounded ex-
tension is a complete extension. The idea of complete ex-
tension is that, a complete labeling can be seen as a subjec-
tive but reasonable point of view that an agent, in our exam-
ple the clinician, can take with respect to which arguments
are in, out and undec. Each point of view is internally co-
herent and if questioned, the agent can use its own position
to defend itself. Someone can disagree with that position,
but can not point out an internal inconsistency. Eventually,
the set of all the complete labelings represent all the possi-
ble and reasonable positions an agent can take [15].
4 Study case
In this study, we have used the Ljubljana breast cancer
dataset1, repeatedly used in many machine learning studies
(1986 up to 2011. Example: [13]). It includes 286 instances
of real patients who went through a breast cancer operation.
9 were incomplete and the others are described by 9 pos-
sible predictive attributes and a binary outcome class (re-
currence or no recurrence). The values (numerical [N] or
categorical [C]) were recorded at time of diagnosis (TD) or
after operation (AO), as shown in Table 1. For 81 patients,
the illness reappeared after 5 years, while 196 did not have
recurrence: data was verified after collection.
Let us assume an expert’s knowledge-base is only based
on the attributes considered in the dataset (Table 1), and it
includes some relationship between attributes and the phe-
nomenon of recurrence. We interviewed an expert in this
field, and asked her to provide such relationships with tangi-
ble and valid literature references, according to her past ex-
perience, intuitions, presumptions and interpretations. This
preliminary set of evidence is depicted in Table 2. From this
evidence, an argumentation framework can now be built,
thus a set of arguments and a set of defeat relations among
arguments is needed.
1provided by the University Medical Center, Institute of Oncology,
Ljubljana, ex-Yugoslavia, by M. Zwitter and M. Soklic (physicians)
Evidence Attribute Description Reference(s)
1 Age The strongest risk factor for breast cancer is age: the older the woman, the higher the risk of cancer (and presumably recurrence). [11]
2 Menopausal Pre-menopausal status is a reason to believe recurrence is not likely. Presumption
3 Tumor size In general, the greatest diameter (in mm) of the excised tumor, the greater the chance of recurrence. Interpretation
4 Node
involvement
Since the axillary lymph nodes act as a primary site of drainage for the breast, they represent common site of early metastasis.
The more lymph nodes involved are, the more likely recurrence is. This is probably the most influential factor for recurrence.
Interpretation
5 Node capsu-
lar invasion
If the cancer does metastasis to a lymph node, even if outside the original tumor site, it can remain ‘contained’ by the lymph
node’s capsule. However, the tumor may replace the lymph node and penetrating the capsule, invading the surrounding tissues.
If capsular invasion, it makes sense that recurrence is more likely.
Interpretation
& Intuition
6 Degree of
malignancy
The histological grade of the tumor affect recurrence. If it is 1, tumors consist of cells that, while neoplastic, retain many of their
usual characteristics, then recurrence is less likely. If it is 2 or 3, tumors consists of highly abnormal cells, with marked variation
in cell size, or a high index of mitotic activity in the cells, therefore making recurrence more likely.
Interpretation
& Intuition
7 Breast Although breast cancer can occur in either breast, there is no difference in incidence between breasts. It seems a slightly higher
(but unexplained) risk of breast cancer, on the left side, exists.
[12]
8 Breast
quadrant
The breast may be divided in four quadrant, using the nipple as a central point. Breast cancer more often occurs in the upper
outer quadrant, and as a consequence this increase the chance of recurrence.
[6]
9 Irradiation Radiotherapy for breast cancer reduces recurrence [7]
10 Age + Meno-
pausal status
Late menopause increases the risk of breast cancer (and presumably recurrence). Women who have undergone the menopause
have a lower risk of breast cancer (and presumably recurrence) than pre-menopausal women of the same age.
[5]
Table 2. A possible expert’s knowledge-base
Label Type Time Values range
Age N TD 10-19, 20-29, 30-39, 40-49, 50-59, 60-69,
70-79, 80-89, 90-99
Menopause C TD lt40, ge40, premeno
Tumor-size N AO 0-4, 5-9, 10-14, 15-19, 20-24, 25-29, 30-34,
35-39, 40-44, 45-49, 50-54, 55-59
Inv-nodes N AO 0-2, 3-5, 6-8, 9-11, 12-14, 15-17, 18-20, 21-
23, 24-26, 27-29, 30-32, 33-35, 36-39
Node-caps C AO yes, no
Deg-malign C AO 1, 2, 3
Breast C AO left, right
Breast-quad C AO left-up, left-low, right-up, right-low, central
Irradiation C AO yes, no
Output class C TD no-recurrence-events, recurrence-events
Table 1. Breast cancer dataset attributes
• An argument is a set of premises whose union supports
a claim: Arg : premise+ ...+ premise→ claim
• A premise is modeled via membership function.
• A claim is what reasonably follows the premise(s).
• (Membership function) For any set X , a membership
function on X is any function f : X → [0, 1] ∈ <.
Membership functions on X represent fuzzy subsets of
X. For an element x of X , the value f(x) is called
the membership degree of x in the fuzzy set and quan-
tifies the grade of membership of x to the fuzzy set
X . (0 indicates non membership while 1 fully mem-
bership; intermediate values refers to fuzzy members,
which partially belong to X). For each fuzzy set X ,
more than one membership function can be defined.
The rationale behind adopting membership is that com-
monly people tend to perceive an entity as being ‘low’ or
‘high’, ‘small’ or ‘big’ and so forth. Intermediate clus-
ters such as ‘medium’ might be used, but generally, peo-
ple avoid more complex scales. For instance, an age of 10
is commonly perceived being a ‘low’ age, with 90 being
‘high’. However, 50 can be considered ‘high’ by an ex-
pert, and ‘medium’ by another. This subjectivity can be
influenced by factors such as past experience, knowledge
or the context. Therefore, membership functions are useful
for modeling vaguely defined sets and dealing with human
reasoning that is approximate rather than fixed and exact.
At this stage, the pool of arguments, needed for the breast
cancer prediction problem, can be built considering the ex-
pert’s knowledge base (Table 2) and her definition of mem-
bership functions over attributes (Figure 2). The output of
this process is shown in Table 3. An example of an argu-
ment is: A : LOW Age → ‘no recurrence′ where the
attribute considered in the premise is ‘Age’, modeled by
membership function fLOWAge () and ‘no recurrence’ is the
claim that reasonably follows the premise. The argument
can be read: ‘a low age is a reason to believe no recurrence’.
Attribute: Age, Evidence: 1 Attribute: Menopause, Evidence: 2
Arg M. f() Claim Arg M. f() Claim
A low no recurrence D pre no recurrence
B medium no recurrence E post-lt40 no recurrence
C high recurrence F post-gt40 recurrence
Attribute: Tumor size, Evidence: 3 Attribute: Node invas., Evidence: 4
Arg M. f() Claim Arg M. f() Claim
G low no recurrence I low no recurrence
H high recurrence J high recurrence
Attribute: Node Caps, Evidence: 5 Attribute: Deg. Malig., Evidence: 6
Arg M. f() Claim Arg M. f() Claim
K true recurrence M low no recurrence
L false no recurrence N high recurrence
Attribute: Breast, Evidence: 7 Attribute: Breast quad, Evidence: 8
Available evidence suggests Arg M. f() Claim
that the attribute breast is not O lower no recurrence
influential, thus no argument is built P upper recurrence
Attribute: Irradiation, Evidence: 9 Attribute: Age+Menop., Evidence: 10
Arg M. f() Claim Arg M. f() Claim
Q true no recurrence R high + pre recurrence
Table 3. Pool of arguments
Membership degrees that produce values greater than
zero will activate the corresponding argument, defining a
new set of arguments. For instance, let us consider a record
of the dataset (as defined in Table 1), related to a patient:
age=40-49, menopause=premeno, Tumor-size=30-34,
Inv-nodes=0-2, Node-caps=no, Deg-malign=2,
breast=right, Breast-quad=right_low, Irradiation=no.
the activated arguments are (of table 3) B, D, H, I, L, N, O.
Figure 2. A possible expert’s Membership functions definition
Once the activated arguments set is built, the set of de-
feat relations among arguments need to be formed, to com-
plete the argumentation framework. Logically, two argu-
ments supporting different claims attack each other. In our
case study, all the arguments supporting ‘recurrence’ attack
all the arguments supporting ’no recurrence’. For the con-
sidered record, the framework built is depicted in fig. 3.
AF=({B,D,H,I,L,N,O},{(H,B),(H,D),(H,I),(H,L),
(H,O),(B,H),(D,H),(I,H),(L,H),(O,H),(N,B),(N,D),
(N,I),(N,L),(N,O),(B,N),(D,N),(I,N),(L,N),(O,N)})
H
IDB L O
N
Figure 3. Argumentation
framework example
Grounded
and preferred
argumentation
semantics can
now be run on
the argumentation
framework built,
for each patient,
to decide which
arguments should
be accepted.
5 Evaluation and analysis of results
The grounded semantic is a skeptical way of computing
acceptable arguments: it returns just one grounded exten-
sion. In our case-study, for 8 records (of 286) a non-empty
grounded extension has been computed, that is a conflict-
free set of arguments supporting the same claim. A clear
coherent position emerges, thus the clinician’s point of view
about recurrence is well-grounded. In 7 of these 8 cases, the
common claim, shared by the arguments in the grounded
extension, coincides with the objective output class of the
dataset’s record (recurrence or not). In the remaining case,
AT fails in predicting the recurrence status: further evi-
dence is needed.
The preferred semantic is a credulous way of computing
acceptable arguments: it returns multiple coherent exten-
sions, each composed by arguments sharing the same claim.
For each record of the dataset, according to our way of con-
structing argumentation frameworks, two preferred exten-
sions exists: one with arguments supporting ‘recurrence’,
and one with arguments supporting ‘no recurrence’. Two
different coherent points of view are available to support the
clinician decision-making process in respect to predicting
the recurrence status. One possible automatic strategy, the
one tested in this study, is the selection of the biggest pre-
ferred extension. Out of 286 patients, 192 recurrence status
were successfully predicted. In 6 cases, the two preferred
extensions had the same size, therefore a further strategy
was required to let an extension emerge. In this study we
selected the extension with less uncertainty. In other words,
each argument in one preferred extension was built upon
a certain attribute, activating one membership function and
producing a membership degree. The average of member-
ship degrees was computed, for each preferred extension,
and the extension with the highest average was chosen (less
uncertain). In 3 cases this strategy was successful while in
other 3 cases the recurrence status was not predicted. How-
ever, this is just an illustrative strategy that can be made
available to the clinician for supporting the final decision.
Intuition suggests that, when possible, a skeptical ap-
proach should be adopted, therefore the common claim sup-
ported by the arguments in the grounded extension should
be used in the decision-making process. If not possible, a
more credulous approach should be applied and a strategy
for selecting the winning preferred extension should be de-
signed. An interesting advantage ofAT is that, the 9 incom-
plete records, part of the original dataset, can still be con-
sidered using our approach. The only difference is that, as
one or more objective values are missing, fewer arguments
will be activated, but still extensions and justification status
can be computed. For these 9 records, the related grounded
extension was empty and our strategy positively predicted 3
cases, by analysing the corresponding preferred extensions.
Results are encouraging. An overall accuracy rate of
71.6% was obtained using AT : (7+ 192 + 3 + 3=205 out of
277+9=286). This rate was compared with the accuracy of
some machine learning classifiers on the same dataset, with
the Weka software [14], with a 10-fold cross-validation.
The classification via logistic function produced an accu-
racy of 68.8%, the alternating decision tree (ADTree) clas-
sifier predicted the input in 73.7% cases, a Bayes network
was successful 72% of the times and a multilayer perceptron
classifier had a precision of 64.7%. These rates suggest that
the preliminary 71.6% obtained with AT is promising and
further investigation can be carried out. Although there is a
initial cost for embedding an expert knowledge’s base into
formal arguments, AT does not require subsequent training
of data. However, AT has advantages and properties that
most machine learning techniques do not have.
• Inconsistency and Incompleteness: AT easily deals
with incomplete and inconsistent data; missing data is
simply discarded and even if an argument cannot be
expressed, the argumentative process can be still exe-
cuted with available arguments. This property is pow-
erful when a full dataset is incomplete or not available;
• Expertise and Uncertainty: AT captures expertise in
a organised fashion, subject to uncertainty;
• Intuitiveness: AT is not based on statistics or proba-
bility. This is close to the way humans reason and if the
designer is anyway inclined to use statistical evidence,
he/she can embed that information in a formal argu-
ment, input of the argumentation framework; therefore
AT provides an intuitive approach for reasoning on
available evidence, even if partial and inconsistent;
• Explainability: AT leads to explanatory reasoning
thanks to the incremental and modular way of reason-
ing with available evidence. AT provides semantics
for computing arguments’ justification status thus let-
ting the final decision be better explained/interpreted;
• Extensibility and Updatability: AT is an an extensible
paradigm that allows to retract a decision in the light
of new evidence: an argumentation framework can be
updated with new arguments.
6. Conclusions and future work
Argumentation theory is an emerging paradigm adopted
in health care for aggregating clinical evidence intuitively
and modularly. It is not a statistical tool and it is close to the
way humans reason under uncertainty with incomplete and
inconsistent evidence. In this study we have presented the
basic building blocks of argumentation theory, and applied
its principles in a real-world health scenario: the breast can-
cer recurrence prediction. We have shown how to trans-
late an expert knowledge-base in arguments and how to ex-
plicitise defeat relations among them in an organised argu-
mentation framework. Subsequently, we have demonstrated
how to interpret the outcomes of the argumentative pro-
ces, and how to enhance an expert decision-making process.
We compared the predictive capacity of our argumentation
theory-based model against well known machine learning
tools. Results are extremely promising, suggesting that fur-
ther research can be carried out to provide clinicians with an
intuitive argumentation framework for supporting and justi-
fying decisions.
Future work will focus on investigating the practicabil-
ity of the approach and the identification of those areas that
would most benefit from the theory. An interface will allow
clinicians to access the argument structure and the exten-
sions, for a given case.
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